Traing Source
BMY Split History ยป
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/12/2018 $62.75 $63.22 $62.52 $62.81 5.49M
01/16/2018 $61.75 $61.86 $59.42 $59.92 14.47M
01/17/2018 $60.33 $62.00 $60.28 $61.85 10.61M
01/18/2018 $61.81 $61.90 $61.10 $61.83 7.90M
01/19/2018 $62.10 $62.42 $61.56 $62.28 7.49M
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus (HIV) infection. Co.'s products include: Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B; and Reyataz is a protease inhibitor for the treatment of HIV.
BMY historical stock prices picture
Bristol-Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on January 12, 2018, BMY opened at $62.75, traded as high as $63.22 and as low as $62.52, and closed at $62.81. Trading volume was a total of 5.49M shares. On January 16, 2018, BMY opened at $61.75, traded as high as $61.86 and as low as $59.42, and closed at $59.92. Trading volume was a total of 14.47M shares. On January 17, 2018, BMY opened at $60.33, traded as high as $62.00 and as low as $60.28, and closed at $61.85. Trading volume was a total of 10.61M shares. On January 18, 2018, BMY opened at $61.81, traded as high as $61.90 and as low as $61.10, and closed at $61.83. Trading volume was a total of 7.90M shares. On January 19, 2018, BMY opened at $62.10, traded as high as $62.42 and as low as $61.56, and closed at $62.28. Trading volume was a total of 7.49M shares.

BMY Historical Stock Prices By Date:

BMY historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol-Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $22.89
End price/share: $62.28
Starting shares: 436.87
Ending shares: 637.87
Dividends reinvested/share: $13.93
Total return: 297.26%
Average Annual Total Return: 14.79%
Starting investment: $10,000.00
Ending investment: $39,722.86
Years: 10.00
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $22.89
End price/share: $62.28
Dividends collected/share: $13.93
Total return: 232.94%
Average Annual Total Return: 12.78%
Starting investment: $10,000.00
Ending investment: $33,290.54
Years: 10.00
Date Close
01/12/2018$62.81
01/16/2018$59.92
01/17/2018$61.85
01/18/2018$61.83
01/19/2018$62.28
BMY is categorized under the Healthcare sector; below are some other companies in the same sector:

BNTC Historical Stock Prices
BOC Historical Stock Prices
BOLD Historical Stock Prices
BONE Historical Stock Prices
BOTA Historical Stock Prices
BPMC Historical Stock Prices
BPMX Historical Stock Prices
BPTH Historical Stock Prices
BRKR Historical Stock Prices
BRLI Historical Stock Prices

BMY Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .